Conference Coverage
Conference Coverage
Ticiana Leal, MDExpert Interviews | August 15, 2025
In the eighth and final segment of this roundtable series, the panel discusses future directions in the field of NSCLC.
View More
Stephen V. Liu, MDConference Coverage | August 15, 2025
Dr. Liu shares why the meeting is a key chance for connections, collaborations, and conversations about the latest data.
Ticiana Leal, MDExpert Interviews | August 15, 2025
In the seventh segment of this roundtable series, the panel discusses how path CR affects postoperative management.
Ticiana Leal, MDExpert Interviews | August 15, 2025
In the sixth segment of this roundtable series, the panel discusses neoadjuvant versus perioperative approaches.
Ticiana Leal, MDExpert Interviews | August 15, 2025
In the fifth segment of this roundtable series, the panel discusses CheckMate 77T, CheckMate 816, and more.
Ticiana Leal, MDExpert Interviews | August 15, 2025
In the fourth segment of this roundtable series, the panel discusses multidisciplinary, comprehensive collaboration.
Balazs Halmos, MDExpert Interviews | August 14, 2025
In the final part of this roundtable series, the panel discusses what the future may hold for NSCLC treatment and surgery.
Balazs Halmos, MDExpert Interviews | August 14, 2025
In the eighth part of this roundtable series, the panel discusses how to minimize the risk of NSCLC recurrence after surgery.
Ticiana Leal, MDExpert Interviews | August 13, 2025
In the second segment of this roundtable series, the panel discusses the importance of safe sampling in biomarker testing.
Ticiana Leal, MDASCO 2025 | August 14, 2025
In the third segment of this roundtable series, the panel discusses resectability and multimodal treatment plans.
Ticiana Leal, MDASCO 2025 | August 12, 2025
In the first segment of this roundtable series, the panel discusses the initial steps in NSCLC diagnosis and treatment.
Balazs Halmos, MDExpert Interviews | August 11, 2025
In the seventh part of this roundtable series, the panel discusses surgical preparations and considerations.
Balazs Halmos, MDExpert Interviews | August 11, 2025
In the sixth segment of this roundtable series, the discusses how multidisciplinary teams monitor and manage AEs.
Balazs Halmos, MDExpert Interviews | August 7, 2025
In the fifth segment of the roundtable series, experts discuss advances in adjuvant, neoadjuvant and perioperative treatment.
Balazs Halmos, MDExpert Interviews | August 5, 2025
In the third part of this roundtable discussion, experts share insights on the decision-making process surrounding treatment
Laura LitwinASCO 2025 | August 4, 2025
Dr. Osarogiagbon discussed the impact of the lung cancer screening program on diagnosis rates across the Mississippi Delta.
Balazs Halmos, MDExpert Interviews | August 4, 2025
In the second segment of this roundtable discussion, experts discuss considerations surrounding biospies and biomarkers.
Jill FeldmanASCO 2025 | July 18, 2025
In the second segment of this interview, Feldman discussed the importance of patient advocacy in clinical trial research.
Cecilia BrownASCO 2025 | July 16, 2025
Thorsten Füreder, MD, shares insights from the NSCLC cohort of the phase 2 trial.
Stephen V. Liu, MDSmall Cell Lung Cancer | July 11, 2025
Dr. Liu explains how these two studies are shaping standards of care and the treatment landscape in SCLC.
Latest News
August 15, 2025